Drug Dispensing Service

Olaparib (Lynparza™)

 Lynparza Breast Cancer Private Sector Patient Programme

Program commencement date

15 November 2021


Application criteria 

1. Valid HKID card holder

2. Adult patients of any private hospitals or private specialist clinics in Hong Kong

3. Medical status (must satisfy all of the followings) :

   ♦ HER2 negative locally advanced or metastatic  breast cancer

   ♦ Harbour germline BRCA 1/2 mutation  

   ♦ Previously treated with an anthracycline and a taxane

   ♦ Patients with hormone receptor (HR) positive breast cancer who have progressed on or after prior endocrine therapy, or be considered unsuitable for endocrine therapy

4. Financial status: Personal monthly income not exceeding HK$ 100,000 in total

5. Having the receipt or purchasing proof with the original prescription of Lynparza issued by any Hong Kong private clinical oncologist or medical oncologist

6. If applicant has already enrolled in any other Lynparza drug assistance program, applicant can only apply this program with prior approval only


For the details and the application procedures of the program, please contact SafeMed Dispensary (Tel: 2979 0380).